Pfizer And Mylan Team Up For Generics Opportunity In Japan
This article was originally published in PharmAsia News
Executive Summary
As the Japanese government tries to boost generics utilization, Pfizer and Mylan plan to leverage combined strengths to become a market leader by 2015.